The CCFR comprises a rich resource of data and biospecimens that has been growing since 1998. See below for an overview1 of the available resources we provide to world leading research.
Recruitment Summary
15,050 Families
42,501 Participants
32,790 Population-based Participants
9,711 Clinic-based Participants
Colorectal Cancer Status
Probands with2 colorectal cancer: 10,030
Probands without3 colorectal cancer: 4,766
Relatives with colorectal cancer: 2,342
Relatives without colorectal cancer: 25,363
Colorectal cancers diagnosed since recruitment: 1,285
Collected Materials
Blood/saliva samples donated by participants: 32,164
Participants with:
- a prevalent CRC tumor specimen (diagnosed prior to recruitment): 8,785
- an incident CRC tumor specimen (diagnosed since recruitment): 397
- a prevalent non-CRC tumor specimen (diagnosed prior to recruitment): 651
- an incident non-CRC tumor specimen (diagnosed since recruitment): 254
RECRUITMENT | Male | Female | Total |
---|---|---|---|
Population-based families |
|
| 13,191 |
Probands with colorectal cancer | 4,321 | 4,418 | 8,739 |
Relatives with colorectal cancer | 521 | 564 | 1,085 |
Relatives without colorectal cancer | 7,209 | 9,773 | 16,982 |
Spouse Controls | 369 | 565 | 934 |
Proband Controls | 2,071 | 2,202 | 4,273 |
Relatives | 310 | 467 | 777 |
Total population-based participants | 14,801 | 17,989 | 32,790 |
Clinic-based families |
|
| 1,859 |
Probands with colorectal cancer | 715 | 671 | 1,386 |
Probands without colorectal cancer | 121 | 277 | 398 |
Relatives with colorectal cancer | 589 | 627 | 1,216 |
Relatives without colorectal cancer | 2,934 | 3,777 | 6,711 |
Total clinic-based participants | 4,359 | 5,352 | 9,711 |
|
|
|
|
Total Participants | 19,160 | 23,341 | 42,501 |
Total Families | 15,040 |
Participant Age at Enrolment

Click images to zoom in
Participation Since Baseline*

*Excludes population-based control families as they were not followed up.
Collected Materials
Population-based families (N=13,191) | Probands with colorectal cancer | Relatives with colorectal cancer | Relatives without colorectal cancer | Controls |
---|---|---|---|---|
Baseline epidemiologic survey data | 8,739 | 1,085 | 16,982 | 5,984 |
1st (~5-year) follow-up epidemiologic/risk-factor survey data | 5,637 | 776 | 13,683 | 2,044 |
2nd (~10-year) follow-up epidemiologic/risk-factor survey data | 4,074 | 583 | 11,012 | 1,250 |
3rd (~15-year) follow-up epidemiologic/risk-factor survey data | 2,891 | 399 | 8,306 | 496 |
4th (~20-year) follow-up epidemiologic/risk-factor survey data | 1,706 | 204 | 5,083
| 346
|
5th (~25-year) follow-up epidemiologic/risk-factor survey data | 530 | 30 | 891 | 19 |
Baseline Food Frequency Questionnaire (FFQ) data | 4,500 | 517 | 7,373 | 3,347 |
Cause of death data | 3,034 | 284 | 1,344 | 478 |
Total person life-years | 98,215 | 14,274 | 268,246 | 53,768 |
– Blood samples (processed into plasma, buffy coat, ficoll -separated lymphocytes, and dried blood spots) | 7,534 | 828 | 10,366 | 3,543 |
– Saliva/buccal samples | 303 | 44 | 832 | 219 |
– EBV transformed lymphoblastoid cell lines | 1,480 | 58 | 79 | 1,237 |
– Germline MMR (MLH1, MSH2, MSH6, PMS2 and/or EPCAM) data | 1,921 | 220 | 1,013 | 45 |
– Germline MutYH data | 7,324 | 153 | 3,031 | 2,541 |
– Genome-wide Association Studies (GWAS) data | 6,284 | 289 | 1,294 | 2,764 |
Colorectal tissue material | ||||
– FFPE tumor tissue | 6,799 | 494 | n/a | n/a |
– FFPE normal tissue | 4,454 | 251 | n/a | n/a |
– Fresh frozen tumors | 41 | 2 | n/a | n/a |
– Fresh frozen normal tissue | 47 | 3 | n/a | n/a |
– CRC tumor 40x digitized H&E images (.svs format) | 4,755 | 362 | n/a | n/a |
– CRC tumor pathology report abstraction data | 8,143 | 645 | n/a | n/a |
– Clinical diagnosis and treatment abstraction data (Phase-I cases) | 3,980 | 105 | n/a | n/a |
– CRC tumor MMR (MSI and/or IHC) data | 6,811 | 488 | n/a | n/a |
– CRC tumor BRAFV600E data | 6,026 | 319 | n/a | n/a |
– CRC tumor KRAS codons 12 and 13 somatic mutation data | 6,012 | 298 | n/a | n/a |
– CRC tumor MLH1 promoter methylation data (tested if MLH1d) | 2,340 | 80 | n/a | n/a |
– CRC tumor CpG-island methylator phenotype (CIMP) data | 3,609 | 154 | n/a | n/a |
Colorectal (CR) FFPE polyps collected | 351 | 41 | 20 | n/a |
– CR polyp pathology report abstraction data | 2,829 | 236 | 338 | 14 |
Clinic-based families (N=1,860) | Probands with colorectal cancer | Probands without colorectal cancer | Relatives with colorectal cancer | Relatives without colorectal cancer |
---|---|---|---|---|
Baseline epidemiologic survey data | 1,386 | 398 | 1,216 | 6,711 |
1st Follow-up epidemiologic survey data | 1,047 | 366 | 968 | 5,892 |
2nd Follow-up epidemiologic survey data | 860 | 328 | 763 | 5,068 |
3rd Follow-up epidemiologic survey data | 609 | 250 | 538 | 3,783 |
4th Follow-up epidemiologic survey data | 288 | 97 | 263 | 1,744 |
5th Follow-up epidemiologic survey data | 35 | 2 | 13 | 79 |
Food Frequency Questionnaire (FFQ) data | 510 | 233 | 694 | 3,793 |
Cause of death data | 276 | 18 | 126 | 215 |
Total person life-years | 18,194 | 5,777 | 15,869 | 101,543 |
– Blood samples (processed into plasma, buffy coat, ficoll -separated lymphocytes and dried blood spots) | 1,271 | 366 | 1,102 | 5,860 |
– Saliva/buccal samples | 8 | 4 | 13 | 61 |
– EBV transformed lymphoblastoid cell lines | 238 | 56 | 22 | 21 |
– Germline MMR (MLH1, MSH2, MSH6, PMS2 and/or EPCAM) data | 802 | 236 | 673 | 2,693 |
– Germline MutYH data | 1,029 | 88 | 22 | 76 |
– Genome-wide Association Studies (GWAS) data | 380 | 32 | 336 | 211 |
Colorectal tissue material | ||||
– FFPE tumors | 1,048 | n/a | 698 | n/a |
– FFPE normal tissue | 463 | n/a | 370 | n/a |
– Fresh frozen tumors | 109 | n/a | 0 | n/a |
– Fresh frozen normal tissue | 116 | n/a | 1 | n/a |
– CRC tumor 40x digitized H&E images (.svs format) | 849 | n/a | 383 | n/a |
– CRC tumor pathology report abstraction data | 1,268 | n/a | 738 | n/a |
– Clinical diagnosis and treatment abstraction data (Phase I) | 654 | n/a | 21 | n/a |
– CRC tumor MMR (MSI and/or IHC) data | 1,076 | n/a | 568 | n/a |
– CRC tumor BRAFv600E data | 896 | n/a | 431 | n/a |
– CRC tumor KRAS codons 12 and 13 somatic mutation data | 919 | n/a | 501 | n/a |
– CRC tumor MLH1 promoter methylation data (tested if MLH1d) | 406 | n/a | 232 | n/a |
– CRC tumor CpG-island methylator phenotype (CIMP) data | 58 | 177 | 56 | n/a |
Colorectal (CR) FFPE polyps collected | 129 | 84 | 124 | 291 |
– CR polyp pathology report abstraction data | 375 | 88 | 265 | 298 |